Clinical Indications for Hydroxyzine
Hydroxyzine is FDA-approved as a first-generation antihistamine primarily for allergic conditions (allergic rhinitis, urticaria) and anxiety, though it should generally be avoided in favor of safer alternatives due to significant risks of sedation, performance impairment, and driving hazards 1.
Primary FDA-Approved Indications
Based on the FDA drug label, hydroxyzine has the following pharmacological properties 1:
- Antihistaminic effects for allergic conditions
- Anxiolytic effects through suppression of subcortical CNS activity
- Bronchodilator activity
- Antiemetic effects
- Mild antisecretory activity
Critical Safety Considerations
Allergic Rhinitis Use - NOT Recommended as First-Line
Second-generation antihistamines are strongly preferred over hydroxyzine for allergic rhinitis treatment 2. The guideline evidence is unequivocal:
- Hydroxyzine causes significant sedation and performance impairment in many patients
- Drivers taking first-generation antihistamines like hydroxyzine are 1.5 times more likely to be responsible for fatal automobile accidents 2
- Performance impairment can exist without subjective awareness of drowsiness 2
- A 2017 French nationwide study confirmed hydroxyzine users had increased crash risk (OR=1.67), particularly those with psychiatric disorders, with highest exposure levels showing OR=2.60 3
- Impaired driving performance with hydroxyzine worsens with cellular phone use 2
Anxiety Disorders - Limited Evidence
For generalized anxiety disorder (GAD):
- A 2010 Cochrane review found hydroxyzine more effective than placebo (OR 0.30) but concluded it cannot be recommended as reliable first-line treatment due to high risk of bias in studies 4
- Studies showed efficacy at 50 mg fixed dose with early cognitive symptom improvement 5
- Equivalent to benzodiazepines and buspirone in limited trials 4
Insomnia - Questionable Benefit
The common practice of adding hydroxyzine at bedtime to aid sleep is not supported by evidence 6:
- A 2014 randomized controlled trial found that adding hydroxyzine 50 mg at night to levocetirizine provided no additional benefit for urticaria symptoms or sleep disturbance compared to levocetirizine alone
- Hydroxyzine actually increased daytime somnolence (P=0.026) 6
- First-generation antihistamines dosed at bedtime cause significant next-day drowsiness and performance impairment due to prolonged half-lives 2
Additional Anticholinergic Risks
Hydroxyzine causes anticholinergic effects including 2:
- Dry mouth and eyes
- Constipation
- Urinary retention
- Risk of narrow-angle glaucoma provocation
- Older adults are particularly vulnerable to falls, fractures, subdural hematomas, and cognitive impairment
Absolute Contraindications
Per FDA labeling 1:
- Known hypersensitivity to hydroxyzine, cetirizine, or levocetirizine
- Prolonged QT interval
- Early pregnancy (teratogenic in animal studies)
- Concomitant use with other CNS depressants increases impairment risk 2
When Hydroxyzine Might Be Considered
The only scenarios where hydroxyzine may have a role:
- Persistent rhinorrhea despite second-generation antihistamine plus intranasal corticosteroid (though topical anticholinergics are preferred) 2
- Short-term insomnia treatment when other therapies failed, not tolerated, or contraindicated 7
- Interstitial cystitis (preliminary evidence only) 8
Before prescribing hydroxyzine, ensure patients understand the significant risks of sedation, performance impairment, driving hazards, and availability of safer alternatives 2.